Anti-cancer effect of a novel 2,3-didithiocarbamate-substituted naphthoquinone as a tumor metabolic suppressor in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  MedChemComm

• Publication date

  2018-04-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c8md00062jPMID 30108954PMCID PMC6072496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.

  2018cited by this paper
• Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform

  2017cited by this paper
• Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.

  2017cited by this paper
• Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase.

  2017cited by this paper
• On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer

  2016cited by this paper
• PKM2, cancer metabolism, and the road ahead

  2016cited by this paper
• Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity

  2016cited by this paper
• Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA

  2015cited by this paper
• Pyruvate kinase M2 at a glance

  2015cited by this paper
• Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression.

  2013cited by this paper
• Targeting cellular metabolism to improve cancer therapeutics

  2013cited by this paper
• PKM2, a Central Point of Regulation in Cancer Metabolism

  2013cited by this paper
• Regulation and function of pyruvate kinase M2 in cancer.

  2013cited by this paper
• Reciprocal Regulation of Protein Kinase and Pyruvate Kinase Activities of Pyruvate Kinase M2 by Growth Signals*

  2013cited by this paper
• Emerging roles of PKM2 in cell metabolism and cancer progression.

  2012cited by this paper
• Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.

  2012cited by this paper
• Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

  2011cited by this paper
• Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2

  2011cited by this paper
• Human pyruvate kinase M2: A multifunctional protein

  2010cited by this paper
• Identification of small molecule inhibitors of pyruvate kinase M2.

  2010cited by this paper
• The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

  2008cited by this paper
• Pyruvate kinase M2 is a phosphotyrosine-binding protein

  2008cited by this paper
• Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphorase.

  2000cited by this paper
• Pten is essential for embryonic development and tumour suppression

  1998cited by this paper
• The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing.

  1986cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• [Origin of cancer cells].

  1956cited by this paper

• Metabolic Plasticity and Cancer Stem Cell Metabolism: Exploring the Glycolysis-OXPHOS Switch as a Mechanism for Resistance and Tumorigenesis

  2025cites this paper
• Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties.

  2024cites this paper
• Association of PKLR gene copy number, expression levels and enzyme activity with 2,3,7,8-TCDD exposure in individuals exposed to Agent Orange/Dioxin in Vietnam.

  2023cites this paper
• Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase.

  2022cites this paper
• Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents.

  2021cites this paper
• Emerging small-molecule inhibitors of the Bruton's tyrosine kinase (BTK): Current development.

  2021cites this paper
• Design, synthesis and biological evaluation of novel dithiocarbamate-substituted diphenylaminopyrimidine derivatives as BTK inhibitors.

  2019cites this paper